Evidence map›Paper›PMID 34124029›Full record

ArticleFrontiers in cell and developmental biology2021

Hepatoma Cell-Derived Extracellular Vesicles Promote Liver Cancer Metastasis by Inducing the Differentiation of Bone Marrow Stem Cells Through microRNA-181d-5p and the FAK/Src Pathway.

Huamei Wei, Jianchu Wang, Zuoming Xu, Wenchuan Li, Xianjian Wu, Chenyi Zhuo, Yuan Lu, Xidai Long, Qianli Tang, Jian Pu

RetractedErratum issuedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Bone-organ axes: bidirectional crosstalk.Military Medical Research · 2024
    Review
  3. Article
  4. Article
  5. [Research progress of mesenchymal stem cell-derived extracellular vesicles in liver diseases].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. The Role of Extracellular Vesicles in Liver Pathogenesis.The American journal of pathology · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Huamei WeiDepartment of Pathology, The Affiliated Hospital of Youjiang Medical College for Nationalities, Guangxi, China.
Jianchu WangClinic Medicine Research Center of Hepatobiliary Diseases, Guangxi, China.
Zuoming XuClinic Medicine Research Center of Hepatobiliary Diseases, Guangxi, China.
Wenchuan LiClinic Medicine Research Center of Hepatobiliary Diseases, Guangxi, China.
Xianjian WuClinic Medicine Research Center of Hepatobiliary Diseases, Guangxi, China.
Chenyi ZhuoGraduate College of Youjiang Medical College for Nationalities, Guangxi, China.
Yuan LuClinic Medicine Research Center of Hepatobiliary Diseases, Guangxi, China.
Xidai LongDepartment of Pathology, The Affiliated Hospital of Youjiang Medical College for Nationalities, Guangxi, China.
Qianli TangClinic Medicine Research Center of Hepatobiliary Diseases, Guangxi, China.
Jian PuClinic Medicine Research Center of Hepatobiliary Diseases, Guangxi, China.
Affiliated Hospital of Youjiang Medical University for Nationalities · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow mesenchymal stem cells (BMSCs) are beneficial to repair the damaged liver. Tumor-derived extracellular vesicles (EV) are notorious in tumor metastasis. But the mechanism underlying hepatoma cell-derived EVs in BMSCs and liver cancer remains unclear. We hypothesize that hepatoma cell-derived EVs compromise the effects of BMSCs on the metastasis of liver cancer. The differentially expressed microRNAs (miRNAs) were screened. HepG2 cells were transfected with miR-181d-5p mimic or inhibitor, and the EVs were isolated and incubated with BMSCs to evaluate the differentiation of BMSCs into fibroblasts. Hepatoma cells were cultured with BMSCs conditioned medium (CM) treated with HepG2-EVs to assess the malignant behaviors of hepatoma cells. The downstream genes and pathways of miR-181d-5p were analyzed and their involvement in the effect of EVs on BMSC differentiation was verified through functional rescue experiments. The nude mice were transplanted with BMSCs-CM or BMSCs-CM treated with HepG2-EVs, and then tumor growth and metastasis

Indexed as

bone marrow mesenchymal stem cellsepithelial-mesenchymal-transitionextracellular vesiclesFAK/Src pathwayliver cancermetastasismicroRNA-181d-5p

Identifiers

PMID34124029
PMCPMC8194264
OpenAlexW4232687896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.